Chemours Company (The) ($CC) Stock Forecast: Down 18.3% Today

What is Chemours Company (The)?

Chemours (CC) operates in the chemical industry, specializing in Advanced Performance Materials and Titanium Technologies. The company experienced a downward trend in its stock value today due to difficulties in its APM segment.

Why is Chemours Company (The) going down?

CC stock is down 18.3% on Feb 20, 2026 19:40

• Chemours (CC) encountered a noticeable earnings shortfall in Q4, primarily due to decreasing sales and profitability in its Advanced Performance Materials sector.
• Despite seeing growth in data-center cooling markets, the disappointing earnings report caused a significant drop in Chemours' stock value.
• Although the company made strategic moves to expand in Thermal & Specialized Solutions and Advanced Performance Materials, the lackluster Q4 performance in the APM segment took the spotlight.
• Chemours' failure to meet earnings expectations and the subsequent decline in its stock price underscore the challenges in the APM division, prompting concerns about the company's financial condition and distress signals.

CC Price Chart

CC Technical Analysis

CC News

Chemours (CC) Reports Q4 Earnings Miss Amid APM Segment Challenges

Chemours (CC) reported a significant Q4 earnings miss, with an 11.3% drop in pre-market trading, primarily due to declining sales and profitability in its Advanced Performance Materials (APM) segment. The company recorded a net loss of $47 million and a substantial decrease in adjusted EBITDA for both the APM and Titanium Technologies segments. Financial health indicators, including a high debt-to-equity ratio and a low Altman Z-Score, suggest potential distress and pose risks for investors.

https://www.gurufocus.com/news/8636936/chemours-cc-reports-q4-earnings-miss-amid-apm-segment-challenges

Chemours Stock Tumbles After Earnings. Data-Center Cooling Couldn’t Save the Quarter.

Chemours stock experienced a sharp decline following a weaker-than-expected earnings report, despite the growth in data-center cooling markets. Prior to this drop, the company's stock had seen significant gains, rising 73% year-to-date and 16% over the past year. However, these positive trends were not enough to offset the disappointing quarterly performance.

https://www.barrons.com/articles/chemours-earnings-stock-price-ai-data-centers-413e910b?gaa_at=eafs&gaa_n=AWEtsqdJoK23y6-lwzzKRSIISrjDerTYE2ES6XAnaODPI8IUiDZCLWhw7MmY&gaa_ts=699888bc&gaa_sig=MM4P0S9Fc-jda814GDlb25oetFZGTfretM4_C3IA_sj8zk4th26XhcipAiD5HAlWs0hri3X7gkhD4K4VOUOVYA%3D%3D

Chemours (CC) Q4 2025 Earnings Call Transcript

Chemours (CC) reported its Q4 2025 earnings, highlighting $300 million in net proceeds from the Kuan Yin site sale for debt reduction and strong free cash flow generation of $92 million. The company projects 3-5% net sales growth and $800-900 million in adjusted EBITDA for the full year 2026, driven by growth in Thermal & Specialized Solutions (TSS) and Advanced Performance Materials (APM), pricing strength in Titanium Technologies (TT), and cost-saving initiatives. Management also discussed strategic actions including TT mining restructuring, capacity expansion at Corpus Christi, and progress in addressing legacy liabilities.

https://www.theglobeandmail.com/investing/markets/markets-news/Motley%20Fool/329452/chemours-cc-q4-2025-earnings-call-transcript/

Chemours slides 11% on Q4 weakness in advanced performance materials (CC:NYSE)

Chemours (CC) shares fell 11% in pre-market trading after reporting weaker-than-expected Q4 adjusted earnings, primarily due to declining sales in its advanced performance materials segment. The company's Q4 net loss increased, and adjusted EBITDA fell significantly year-over-year. Despite the poor Q4 performance, Chemours provided a full-year revenue growth forecast of 3%-5% and adjusted EBITDA of $800M-$900M, which aligns with analyst expectations.

https://seekingalpha.com/news/4554618-chemours-slides-11-on-q4-weakness-in-advanced-performance-materials

Earnings Flash (CC) Chemours Posts Q4 Adjusted EPS $0.05, vs. FactSet Est of $0.07

The Chemours Company reported Q4 adjusted earnings per share of $0.05, falling short of FactSet's estimate of $0.07. Revenue for the quarter was $1.33 billion, matching FactSet's estimate. The company's shares declined after hours following the announcement of decreased Q4 adjusted earnings and sales.

https://www.marketscreener.com/news/earnings-flash-cc-chemours-posts-q4-adjusted-eps-0-05-vs-factset-est-of-0-07-ce7e5ddcd18ff120

Trending Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Up 31.3% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Up 6.1% Today

Fiverr International Ltd. ($FVRR) Stock Forecast: Up 5.1% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Up 5.3% Today

Etsy Inc. ($ETSY) Stock Forecast: Up 9.8% Today

Corning Incorporated ($GLW) Stock Forecast: Up 5.8% Today

Chemours Company (The) ($CC) Stock Forecast: Down 18.3% Today

Oracle Corporation ($ORCL) Stock Forecast: Down 5.2% Today

Digital Ocean Holdings ($DOCN) Stock Forecast: Down 5.2% Today

Live Nation Entertainment Inc. ($LYV) Stock Forecast: Up 5.4% Today

Chemours Company (The) Price History

22.00.2026 - CC Stock was up 5.3%

• Chemours' stock price surged by 8.2%, driven by the recent sale of its Taiwan titanium dioxide facility for $360 million. This transaction was viewed as a strategic move to bolster liquidity, reduce debts, and address existing obligations, thereby uplifting investor confidence in the company's financial position.
• The divestment of the dormant manufacturing site is in line with Chemours' initiative to streamline its business portfolio, emphasizing core segments like advanced performance materials and sustainable solutions. This shift of resources towards innovative sectors likely resonated positively with investors, impacting the stock performance.
• Insights derived from AI-driven analysis by market experts suggest a favorable market sentiment in the short and medium term for Chemours, highlighting an attractive risk-reward ratio and the potential for substantial returns. The positive market outlook, coupled with the company's strategic restructuring efforts, contributed to the bullish trend in Chemours' stock today.

04.01.2026 - CC Stock was up 9.1%

• Chemours' bullish market movement today could be attributed to the company's efforts to improve its financial health by divesting assets and appointing new leadership to drive a turnaround in its Titanium Technologies segment.
• The surge in Chemours' share price may also be influenced by investors reacting positively to the company's actions to address its operational challenges and environmental liabilities.
• Despite concerns about limited growth potential and job cuts at mining facilities, the market may be optimistic about Chemours' future prospects based on the recent developments and potential for improved efficiency in operations.
• The technical analysis and AI-generated trading strategies highlighting a risk-reward setup and distinct trading strategies could have also contributed to the bullish momentum in Chemours' stock today.

21.00.2026 - CC Stock was up 6.5%

• The sale of Chemours' former titanium dioxide manufacturing site in Taiwan for approximately $360 million is seen as a positive strategic move by investors, leading to increased confidence in the company's financial outlook.
• By divesting the inactive site and using the proceeds to reduce debt obligations, Chemours is demonstrating a commitment to optimizing its portfolio and focusing on core business areas, which is well-received by the market.
• Despite facing legal risks from a PFAS class action lawsuit, the company's proactive approach to strengthening its financial position through asset sales is viewed favorably by investors, overshadowing concerns about potential legal challenges.
• The market's positive reaction to Chemours' debt reduction plans and strategic reallocation of resources reflects a growing emphasis on sustainability and efficiency in the industry, positioning the company for long-term growth and competitiveness.

06.01.2026 - CC Stock was up 5.5%

• Chemours (CC) stock saw a bullish trend today, possibly driven by the anticipation surrounding its upcoming fourth-quarter 2025 earnings release and conference call.
• The market may be reacting positively to the potential for long-term prospects, especially in the titanium dioxide (TiO2) business, despite analysts' expectations of a decline in EPS and revenue for the quarter.
• The announcement of a sustainable 2% yield for Chemours could have also contributed to investor interest in the stock, emphasizing the importance of dividends for total stock market returns.
• Overall, the bullish movement in CC's stock today could be a reflection of investor optimism towards the company's future performance and strategic initiatives, despite near-term challenges.

05.01.2026 - CC Stock was down 5.0%

• The company announced its fourth-quarter 2025 financial results, with analysts expecting a decline in earnings per share and revenue from the previous quarter, influencing the bearish movement in the stock.
• Despite long-term optimism surrounding potential market turnarounds in its titanium dioxide business, weak quarterly performance and reduced EPS estimates weighed on investor sentiment, contributing to the bearish trend.
• Strategic moves to strengthen the balance sheet through divestments and leadership changes in key segments were overshadowed by the anticipation of challenging Q4 results, impacting the market sentiment negatively.
• Chemours received an upgrade in its Relative Strength Rating, indicating improving technical performance; however, this positive development was overshadowed by concerns regarding the company's financial performance and operational challenges, leading to the bearish market movement.

03.01.2026 - CC Stock was up 5.1%

• Chemours' stock price has recently increased by 27%, although it remains 14% lower than the previous year, which may suggest undervaluation attracting investor interest.
• The company's low Price-to-Sales (P/S) ratio compared to industry peers indicates a potential value play for investors rather than growth expectations.
• Layoffs at the Georgia mining facilities may signal a strategic shift towards high-value minerals and improved efficiency, seen as a positive move by investors focused on cost-saving measures.
• Concerns around PFAS contamination for private well owners are shedding light on environmental issues within the chemical industry, potentially driving pressure on companies like Chemours to address sustainability and regulatory challenges.
• The recent acquisition of a significant position in Chemours by Y Intercept Hong Kong Ltd signifies confidence in the company's future, despite earnings estimates being missed, showcasing a contrast in market sentiment and institutional support.

16.00.2026 - CC Stock was up 8.0%

• The sale of the former titanium dioxide manufacturing site in Taiwan for $360 million cash has positively impacted CC's financial stability and liquidity.
• The strategic move to focus on core business areas and optimize market strategy following the sale could have boosted investor confidence in CC's future prospects.
• Despite a recent EPS miss in Q3 2025, the company's management of its global manufacturing footprint and debt reduction efforts seem to have resonated well with investors, leading to the bullish market movement.

16.00.2026 - CC Stock was up 5.1%

• Two investment firms upgraded their price targets for Chemours, reflecting a positive view on the company's performance and growth potential.
• Chemours recently sold a titanium dioxide manufacturing site in Taiwan for $360 million, a move expected to enhance its financial position by reducing debt.
• Despite a recent earnings per share disappointment in Q3 2025, analysts maintain a positive outlook on Chemours, particularly in the titanium dioxide sector, emphasizing its high-risk, high-reward investment nature.
• The market reacted favorably to the asset sales and price target upgrades, fueling the upward momentum in Chemours' stock price.

20.01.2026 - CC Stock was down 14.3%

• CC reported Q4 earnings that fell short of analyst estimates, with adjusted EPS at $0.05 compared to the expected $0.07, and revenue of $1.3 billion missing the estimated $1.33 billion.
• Despite the earnings miss, the stock experienced significant growth in the last three months, up 84.71%, and 16.76% in the last twelve months, indicating positive investor sentiment prior to the recent earnings report.
• The company attributed the net loss in Q4 and full year to lower cost absorption, non-cash inventory charges, and litigation-related expenses, impacting its financial performance.
• Chemours Co. anticipates future growth in net sales and adjusted EBITDA for 2026, driven by Opteon™ Refrigerants demand and strategic cost reductions, providing a positive outlook despite the current earnings disappointment.

20.01.2026 - CC Stock was down 21.2%

• Chemours (CC) experienced a notable Q4 earnings shortfall, attributed to a decline in sales and profitability within its Advanced Performance Materials segment, resulting in a downturn in the market.
• Despite an uptick in data-center cooling markets, disappointing Q4 performance and earnings contributed to a substantial drop in Chemours' stock value.
• The company's failure to meet estimated Q4 adjusted EPS as per FactSet and the announcement of reduced earnings and sales intensified bearish sentiments.
• Going forward, Chemours projects revenue growth in 2026 driven by Opteon™ Refrigerants demand and cost-saving initiatives, potentially reversing the current downward trajectory of the stock.

10.01.2026 - CC Stock was up 5.2%

• The stock hit a 52-week high due to strong investor confidence and significant gains over the past six months, despite operating with substantial debt.
• Analysts predict profitability this year, with an EPS of $0.91, reflecting positive sentiment towards the company's financial performance.
• The increased stake by the New York State Common Retirement Fund by over 1,000% in Q3 also contributed to the bullish movement, indicating growing institutional interest in Chemours.
• The announcement of the upcoming fourth-quarter earnings release and conference call may have further boosted investor optimism, providing a catalyst for the stock's upward momentum.

20.01.2026 - CC Stock was down 18.3%

• Chemours (CC) encountered a noticeable earnings shortfall in Q4, primarily due to decreasing sales and profitability in its Advanced Performance Materials sector.
• Despite seeing growth in data-center cooling markets, the disappointing earnings report caused a significant drop in Chemours' stock value.
• Although the company made strategic moves to expand in Thermal & Specialized Solutions and Advanced Performance Materials, the lackluster Q4 performance in the APM segment took the spotlight.
• Chemours' failure to meet earnings expectations and the subsequent decline in its stock price underscore the challenges in the APM division, prompting concerns about the company's financial condition and distress signals.